A Practical Guide to Full Value of Vaccine Assessments
Articulating the wide range of health, social and economic benefits that vaccines offer may help to overcome obstacles in the vaccine development pipeline. A framework to guide the assessment and communication of the value of a vaccine—the Full Value of Vaccine Assessment (FVVA)—has been developed b...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/2/201 |
| _version_ | 1797296873148514304 |
|---|---|
| author | Caroline Trotter Birgitte Giersing Ann Lindstrand Naor Bar-Zeev Tania Cernuschi Lauren Franzel-Sassanpour Martin Friede Joachim Hombach Maarten Jansen Mateusz Hasso-Agopsowicz Mitsuki Koh So Yoon Sim Dijana Spasenoska Karene Hoi Ting Yeung Philipp Lambach |
| author_facet | Caroline Trotter Birgitte Giersing Ann Lindstrand Naor Bar-Zeev Tania Cernuschi Lauren Franzel-Sassanpour Martin Friede Joachim Hombach Maarten Jansen Mateusz Hasso-Agopsowicz Mitsuki Koh So Yoon Sim Dijana Spasenoska Karene Hoi Ting Yeung Philipp Lambach |
| author_sort | Caroline Trotter |
| collection | DOAJ |
| description | Articulating the wide range of health, social and economic benefits that vaccines offer may help to overcome obstacles in the vaccine development pipeline. A framework to guide the assessment and communication of the value of a vaccine—the Full Value of Vaccine Assessment (FVVA)—has been developed by the WHO. The FVVA framework offers a holistic assessment of the value of vaccines, providing a synthesis of evidence to inform the public health need of a vaccine, describing the supply and demand aspects, its market and its impact from a health, financial and economic perspective. This paper provides a practical guide to how FVVAs are developed and used to support investment in vaccines, ultimately leading to sustained implementation in countries. The FVVA includes a range of elements that can be broadly categorised as synthesis, vaccine development narrative and defining vaccine impact and value. Depending on the features of the disease/vaccine in question, different elements may be emphasised; however, a standardised set of elements is recommended for each FVVA. The FVVA should be developed by an expert group who represent a range of stakeholders, perspectives and geographies and ensure a fair, coherent and evidence-based assessment of vaccine value. |
| first_indexed | 2024-03-07T22:11:06Z |
| format | Article |
| id | doaj.art-71c0c6ee4fc0484584bb373fac104226 |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-07T22:11:06Z |
| publishDate | 2024-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-71c0c6ee4fc0484584bb373fac1042262024-02-23T15:37:10ZengMDPI AGVaccines2076-393X2024-02-0112220110.3390/vaccines12020201A Practical Guide to Full Value of Vaccine AssessmentsCaroline Trotter0Birgitte Giersing1Ann Lindstrand2Naor Bar-Zeev3Tania Cernuschi4Lauren Franzel-Sassanpour5Martin Friede6Joachim Hombach7Maarten Jansen8Mateusz Hasso-Agopsowicz9Mitsuki Koh10So Yoon Sim11Dijana Spasenoska12Karene Hoi Ting Yeung13Philipp Lambach14Disease Dynamics Unit, Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UKImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandImmunization Department, World Health Organization, 1202 Geneva, SwitzerlandArticulating the wide range of health, social and economic benefits that vaccines offer may help to overcome obstacles in the vaccine development pipeline. A framework to guide the assessment and communication of the value of a vaccine—the Full Value of Vaccine Assessment (FVVA)—has been developed by the WHO. The FVVA framework offers a holistic assessment of the value of vaccines, providing a synthesis of evidence to inform the public health need of a vaccine, describing the supply and demand aspects, its market and its impact from a health, financial and economic perspective. This paper provides a practical guide to how FVVAs are developed and used to support investment in vaccines, ultimately leading to sustained implementation in countries. The FVVA includes a range of elements that can be broadly categorised as synthesis, vaccine development narrative and defining vaccine impact and value. Depending on the features of the disease/vaccine in question, different elements may be emphasised; however, a standardised set of elements is recommended for each FVVA. The FVVA should be developed by an expert group who represent a range of stakeholders, perspectives and geographies and ensure a fair, coherent and evidence-based assessment of vaccine value.https://www.mdpi.com/2076-393X/12/2/201full value of vaccine assessmentvaccine developmentvaccine pipelinevaccine value |
| spellingShingle | Caroline Trotter Birgitte Giersing Ann Lindstrand Naor Bar-Zeev Tania Cernuschi Lauren Franzel-Sassanpour Martin Friede Joachim Hombach Maarten Jansen Mateusz Hasso-Agopsowicz Mitsuki Koh So Yoon Sim Dijana Spasenoska Karene Hoi Ting Yeung Philipp Lambach A Practical Guide to Full Value of Vaccine Assessments Vaccines full value of vaccine assessment vaccine development vaccine pipeline vaccine value |
| title | A Practical Guide to Full Value of Vaccine Assessments |
| title_full | A Practical Guide to Full Value of Vaccine Assessments |
| title_fullStr | A Practical Guide to Full Value of Vaccine Assessments |
| title_full_unstemmed | A Practical Guide to Full Value of Vaccine Assessments |
| title_short | A Practical Guide to Full Value of Vaccine Assessments |
| title_sort | practical guide to full value of vaccine assessments |
| topic | full value of vaccine assessment vaccine development vaccine pipeline vaccine value |
| url | https://www.mdpi.com/2076-393X/12/2/201 |
| work_keys_str_mv | AT carolinetrotter apracticalguidetofullvalueofvaccineassessments AT birgittegiersing apracticalguidetofullvalueofvaccineassessments AT annlindstrand apracticalguidetofullvalueofvaccineassessments AT naorbarzeev apracticalguidetofullvalueofvaccineassessments AT taniacernuschi apracticalguidetofullvalueofvaccineassessments AT laurenfranzelsassanpour apracticalguidetofullvalueofvaccineassessments AT martinfriede apracticalguidetofullvalueofvaccineassessments AT joachimhombach apracticalguidetofullvalueofvaccineassessments AT maartenjansen apracticalguidetofullvalueofvaccineassessments AT mateuszhassoagopsowicz apracticalguidetofullvalueofvaccineassessments AT mitsukikoh apracticalguidetofullvalueofvaccineassessments AT soyoonsim apracticalguidetofullvalueofvaccineassessments AT dijanaspasenoska apracticalguidetofullvalueofvaccineassessments AT karenehoitingyeung apracticalguidetofullvalueofvaccineassessments AT philipplambach apracticalguidetofullvalueofvaccineassessments AT carolinetrotter practicalguidetofullvalueofvaccineassessments AT birgittegiersing practicalguidetofullvalueofvaccineassessments AT annlindstrand practicalguidetofullvalueofvaccineassessments AT naorbarzeev practicalguidetofullvalueofvaccineassessments AT taniacernuschi practicalguidetofullvalueofvaccineassessments AT laurenfranzelsassanpour practicalguidetofullvalueofvaccineassessments AT martinfriede practicalguidetofullvalueofvaccineassessments AT joachimhombach practicalguidetofullvalueofvaccineassessments AT maartenjansen practicalguidetofullvalueofvaccineassessments AT mateuszhassoagopsowicz practicalguidetofullvalueofvaccineassessments AT mitsukikoh practicalguidetofullvalueofvaccineassessments AT soyoonsim practicalguidetofullvalueofvaccineassessments AT dijanaspasenoska practicalguidetofullvalueofvaccineassessments AT karenehoitingyeung practicalguidetofullvalueofvaccineassessments AT philipplambach practicalguidetofullvalueofvaccineassessments |